Contraception in the Perimenopause
| Autor: | Ailsa Gebbie |
|---|---|
| Rok vydání: | 2003 |
| Předmět: |
medicine.medical_specialty
media_common.quotation_subject medicine.medical_treatment Population Fertility Intrauterine device Medicine Humans Levonorgestrel education media_common Climacteric Gynecology Pregnancy education.field_of_study business.industry Obstetrics Estrogen Replacement Therapy Obstetrics and Gynecology Hormone replacement therapy (menopause) medicine.disease Menopause Contraceptives Oral Combined Contraception Family planning Female business medicine.drug |
| Zdroj: | British Menopause Society Journal. 9:123-128 |
| ISSN: | 1362-1807 |
| DOI: | 10.1177/136218070300900311 |
| Popis: | The perimenopause is a stage of life when a woman has low fertility but still requires contraception. It is also a peak age for menstrual dysfunction and a time when menopausal symptoms may commence. All these factors impact on contraceptive choice. Combined oral contraception can be continued until the age of 50 years in women who are low risk and do not smoke. Progestogen-only methods have advantages for women who have risk factors for cardiovascular disease. An intrauterine device may exacerbate menstrual problems at this stage but the levonorgestrel releasing intrauterine system is highly effective in controlling perimenopausal menstrual dysfunction. Women should receive accurate individualised advice on how the risks and benefits of contraceptive methods relate to them and on when contraception can be safely discontinued. Hormone replacement therapy is not reliably contraceptive and women should be advised to continue with a contraceptive method until they have reached natural sterility. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|